"name","text","label","uuid:ID","instanceType","id","description"
"OBJ1","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","","f54012f4-45e4-424d-acfc-a4342ae9f2d9","OBJECTIVE","Objective_1","Main objective"
"OBJ2","To document the safety profile of the xanomeline TTS.","","5d37814c-79db-433d-a69f-b1c68eb0d287","OBJECTIVE","Objective_2","Safety"
"OBJ3","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","","2da7e4b5-8b10-4fb9-afb2-40ba60e1492d","OBJECTIVE","Objective_3","Behaviour"
